If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2006, Ph.D. (Life Science), National Tsing Hua University
  • 2000, B.S. (Life Science), National Tsing Hua University

Experience

  • 2019- Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2018- Associate Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
  • 2016-2018 Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2012-2016 Assistant Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2007-2009 Postdoctoral fellow, National Taiwan University College of Medicine

Awards

  • 2012 Young Investigator Award, The Pharmacological Society in Taiwan

Research Interests

  • Cancer Biology
  • Pharmacology
  • Epigenetics

URL

Fingerprint Dive into the research topics where Pei-Ming Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 3652 Citations
  • 18 h-Index
  • 47 Article
  • 2 Comment/debate
  • 2 Review article
  • 1 Editorial
  • Open Access
  • Sorafenib inhibits ribonucleotide reductase regulatory subunit M2 (RRM2) in hepatocellular carcinoma cells

    Yang, P. M., Lin, L. S. & Liu, T. P., Jan 2020, In : Biomolecules. 10, 1, 117.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)
    Open Access
  • 2 Citations (Scopus)